Acta Scientific Medical Sciences (ASMS)(ISSN: 2582-0931)

Editorial Volume 6 Issue 5

COVID-19. Is it Still Pandemic or Endemic? What is its Future in 2022?

Salim Surani1* and Minahil Saleem2

1Clinical Professor, Texas A&M University, Texas USA
2MSIII Dow Medical College, Karachi, Pakistan

*Corresponding Author: Salim Surani, Clinical Professor, Texas A&M University, Texas USA.

Received: March 21, 2022; Published: March 30, 2022

The SARS-CoV2 or severe respiratory syndrome Cov2 or COVID-19, since its origin in the wet seafood market in Wuhan, China, in late 2019, has taken the world by storm affecting almost 467 million people globally, with 6,089,773 people being succumbed to this disease worldwide [1]. In 2020, scientists focused on antiviral therapy, vaccines, and the role of repurposing medications. The vaccine came as a winner, hands down, with the Pfizer vaccine for COVID-19 making its way in late 2020. This was followed by several vaccines such as Moderna, AstraZeneca, Sinovac, Sputnik, Sinopharm, to name a few. As the vaccine supply was emerging, so was the disparity. In the initial phase, the developed country vaccination rate was far higher than the developing countries [2].


  1. “Covid-19 Pandemic” (2022).
  2. Doroftei B., et al. “Mini-Review Discussing the Reliability and Efficiency of COVID-19 Vaccines”. Diagnostics (Basel)4 (2021): 579.
  3. “Statement – Update on COVID-19: Europe and central Asia again at the epicentre of the pandemic”. World Health Organization (2022).
  4. Raman R., et al. “COVID-19: Unmasking Emerging SARS-CoV-2 Variants, Vaccines and Therapeutic Strategies”. Biomolecules 7 (2021): 993.
  5. “Omicron Subvariant BA.2 Now Accounts for Nearly 25% Of New U.S. Covid Cases Being Sequenced 2022” (2022).
  6. “Everything you need to know about Deltacron and COViD-19 vaccines of concern. GAVI, the vaccine alliance” (2022).
  7. Surani S., et al. “Call for a Global Vaccine Plan to Combat Current and Future Pandemics: One for ALL and ALL for One”. 16 (2022): e187430642202040.


Citation: Salim Surani and Minahil Saleem. “COVID-19. Is it Still Pandemic or Endemic? What is its Future in 2022?”.Acta Scientific Medical Sciences 6.5 (2022): 01-03.


Copyright: © 2022 Salim Surani and Minahil Saleem. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Acceptance rate30%
Acceptance to publication20-30 days
Impact Factor1.403

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is July 10, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US